DENTSPLY International (XRAY) : Headinvest reduced its stake in DENTSPLY International by 0.46% during the most recent quarter end. The investment management company now holds a total of 98,921 shares of DENTSPLY International which is valued at $6,191,465 after selling 455 shares in DENTSPLY International , the firm said in a disclosure report filed with the SEC on Jul 26, 2016.DENTSPLY International makes up approximately 2.29% of Headinvest’s portfolio.
Other Hedge Funds, Including , Candriam Luxembourg S.c.a. boosted its stake in XRAY in the latest quarter, The investment management firm added 73,230 additional shares and now holds a total of 212,680 shares of DENTSPLY International which is valued at $13,311,641. DENTSPLY International makes up approx 0.34% of Candriam Luxembourg S.c.a.’s portfolio.Shell Asset Management Co boosted its stake in XRAY in the latest quarter, The investment management firm added 9,150 additional shares and now holds a total of 25,070 shares of DENTSPLY International which is valued at $1,569,131. DENTSPLY International makes up approx 0.04% of Shell Asset Management Co’s portfolio.Ruane Cunniff Goldfarb Inc reduced its stake in XRAY by selling 138,075 shares or 2.85% in the most recent quarter. The Hedge Fund company now holds 4,705,249 shares of XRAY which is valued at $295,348,480. DENTSPLY International makes up approx 2.73% of Ruane Cunniff Goldfarb Inc’s portfolio.Foundry Partners reduced its stake in XRAY by selling 58,029 shares or 55.37% in the most recent quarter. The Hedge Fund company now holds 46,777 shares of XRAY which is valued at $2,946,015. DENTSPLY International makes up approx 0.28% of Foundry Partners’s portfolio.
DENTSPLY International opened for trading at $63.23 and hit $64.18 on the upside on Friday, eventually ending the session at $64.04, with a gain of 1.49% or 0.94 points. The heightened volatility saw the trading volume jump to 21,90,152 shares. Company has a market cap of $15,000 M.
On the company’s financial health, DENTSPLY International reported $0.69 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on May 6, 2016. Analyst had a consensus of $0.62. The company had revenue of $772.60 million for the quarter, compared to analysts expectations of $778.36 million. The company’s revenue was up 17.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.59 EPS.
Many Wall Street Analysts have commented on DENTSPLY International. DENTSPLY International was Initiated by Piper Jaffray to “Overweight” on Jun 13, 2016. Company shares were Reiterated by Barrington Research on May 13, 2016 to “Outperform”, Firm has raised the Price Target to $ 68 from a previous price target of $62 .
DENTSPLY International Inc. is a designer developer manufacturer and marketer of a range of consumable dental products for the professional dental market. It operates through three segments: Dental Consumable and Certain International Businesses; Dental Specialty and Laboratory and Certain Global Distribution Businesses and Healthcare and Emerging Markets Businesses. All the segments are primarily engaged in the design manufacture and distribution of dental and medical products in four product categories. Its Dental Consumable Products consist of dental supplies and devices and small equipment used in dental offices. Its Dental Laboratory Products are used in the preparation of dental appliances by dental laboratories. Its Dental Specialty Products are specialized treatment products used within the dental office and laboratory settings. Its Consumable Medical Device Products consist mainly of urology catheters certain surgical products medical drills and other products.